GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Tariff Resilience Score

iZafe Group AB (OSTO:IZAFE B) Tariff Resilience Score : 0/10 (As of Jul. 15, 2025)


View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB Tariff Resilience Score?

iZafe Group AB has the Tariff Resilience Score of 0, which implies that the company might have .

iZafe Group AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes iZafe Group AB might have .


iZafe Group AB  (OSTO:IZAFE B) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

iZafe Group AB Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.


iZafe Group AB Business Description

Traded in Other Exchanges
Address
David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines